查看: 1600|回复: 10
|
【UMC 0256 交流专区】
[复制链接]
|
|
本帖最后由 icy97 于 14-9-2022 09:26 AM 编辑
(吉隆坡26日讯)UMediC集团获得大马交易所批准在创业板上市,该公司将通过首次公开售股(IPO)发售9722万新股,以集资建厂扩充产能。
UMediC集团的主要业务是研发、生产和销售医疗器材。该公司通过IPO发售的9722万股当中,有1870万股供大马公众认购,另外1309万股分配予合格董事、雇员及对公司有贡献者,剩馀的6544万股则私下配售予特定投资者。
同时,UMediC集团执行董事兼首席执行员林椿雄表示,“随著医疗器材需求逐渐成长,该公司将把握机会强化公司规模。”
他说,IPO集资额将用于建设新工厂,以扩张产能应付逐渐增加的产品需求。
艾芬黄氏投行是UMediC集团的IPO主要顾问、保荐商、配售商和包销商。 |
|
|
|
|
|
|
|
楼主 |
发表于 28-7-2022 01:38 PM
|
显示全部楼层
UMediC集团(UMC,0256,创业板)的日线股价趋势于7月26日间显现着一段技术反弹走势,闭市时报44仙,按日涨12仙或37.5%。短期间该股或会上挑44.5至56仙水平。
26/7/22行情
闭市:44仙
起落:+12仙
成交量:1,234,822宗
最高:55仙
最低:43.5仙
本益比:--
毛周息率:--
52周最高:55仙
52周最低:--
UMediC集团股价走势26/07/22 |
|
|
|
|
|
|
|
楼主 |
发表于 28-7-2022 01:40 PM
|
显示全部楼层
(吉隆坡26日讯)医疗器械分销商UMediC集团(UMC,0256,创业板),今日正式上市马股创业板,首日登场获投资者大力追捧,股价一度飙涨近72%。
该股今早首宗交易以每股50仙开盘,比起首次公开募股(IPO)每股32仙的发售价,溢价18仙或56.25%。随后,该股一度攀抵55仙的高峰,涨幅达72%。
周二闭市时,UMediC集团收在44仙,比发售价高溢价12仙或37.5%,交易量高达1亿2348万2200股,是全场最活跃股项。
集团主席拿督黄才荣的替任董事黄振亮,今天在记者会上表示,对于股价表现感到欣喜,“这证明了投资者对集团业务的信心,同时也给管理层继续前进的动力。”
“我们将在未来继续扩大业务,生产更多自制产品,扩大产品种类。”
产品获清真认证
执行董事兼总执行长林椿雄今天也捎来好消息,即集团的医用加湿器(prefilled humidifier)已获得了清真认证和欧洲合格认证。
“我们的产品在穆斯林国家很受欢迎,这是一个巨大商机。”
有关成本高涨问题,黄振亮指出,这是全球性问题,所幸集团从事的行业是与至关紧要的医疗领域,因此可将成本转嫁给客户。
“无论是持续的地缘政治紧张或高通胀压力,当你生病时,你终究需要医疗。”
目前,该集团的产品有出口至30个国家,其中亚太地区占最多,这包括了韩国、泰国、印尼等国家。
今天出席鸣锣仪式的,还有独立非执行董事陈彩碹、刘继襁、李毅潍以及帕基里萨米博士。
UMediC集团上市鸣锣
林椿雄(左三)和黄才荣(右四)为UMediC集团上市鸣锣,由陈彩碹(左起)、刘继襁、黄振亮、李毅潍和帕基里萨米陪同。
首三季业绩亮眼
UMediC集团2022财年累积9个月的净利报585万8000令吉,倘若撇除本次上市费用,则录得705万令吉净利,比上年全年经调整净利561万令吉,高出25.7%。
同时,首三季营业额录得了4332万7000令吉,比上年全年的3411万6000令吉,高出了27%。
其中,84%来自分销业务,而制造业务仅占16%,并有意扩大后者业务至占总营收的50%。
林椿雄透露,与去年相比,今年的订单有强劲的双位数增长。
集团上市所筹得的3111万令吉,11.3%用于扩建新厂,21.9%在吉隆坡和柔佛设新分销办公室,28.9%偿还贷款,27.8%充作营运资本,及10.1%为上市费用。 |
|
|
|
|
|
|
|
发表于 14-9-2022 09:27 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jul 2022 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jul 2022 | 31 Jul 2021 | 31 Jul 2022 | 31 Jul 2021 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 7,411 | 0 | 50,738 | 34,116 | 2 | Profit/(loss) before tax | 304 | 0 | 8,482 | 6,554 | 3 | Profit/(loss) for the period | 568 | 0 | 6,426 | 5,087 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 568 | 0 | 6,426 | 5,087 | 5 | Basic earnings/(loss) per share (Subunit) | 0.15 | 0.00 | 1.72 | 1.36 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1409 | 0.0421
|
|
|
|
|
|
|
|
|
发表于 15-3-2023 07:07 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jan 2023 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jan 2023 | 31 Jan 2022 | 31 Jan 2023 | 31 Jan 2022 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 12,518 | 0 | 23,832 | 0 | 2 | Profit/(loss) before tax | 3,725 | 0 | 5,973 | 0 | 3 | Profit/(loss) for the period | 2,909 | 0 | 4,910 | 0 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 2,909 | 0 | 4,910 | 0 | 5 | Basic earnings/(loss) per share (Subunit) | 0.78 | 0.00 | 1.31 | 0.00 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1540 | 0.1409
|
|
|
|
|
|
|
|
|
发表于 15-3-2023 07:13 AM
|
显示全部楼层
本帖最后由 icy97 于 15-3-2023 07:14 AM 编辑
Date of change | 06 Mar 2023 | Name | MISS NG SZE HUI | Age | 27 | Gender | Female | Nationality | Malaysia | Designation | Alternate Director | Directorate | Executive | Type of change | Appointment | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | 1 | Masters | Master of Laws and Bar Professional Training Course | University of London | | 2 | Degree | Bachelor of Laws | London School of Economics andPolitical Science | |
Working experience and occupation | 2020: Wong & Partners (Baker McKenzie International)2020-2021: Azmi & Associates (TerraLex Worldwide)2021-2022: Legal and Corporate Adviser UMediC Group BerhadPresent: Legal and Product Development Manager UMediC Group Berhad | Directorships in public companies and listed issuers (if any) | Nil | Family relationship with any director and/or major shareholder of the listed issuer | Ng Sze Hui is the daughter of Dato' Ng Chai Eng, the Non-Independent Non-Executive Chairman and major shareholder of UMediC Group Berhad.She is also the cousin of Mr. Lim Taw Seong, the Executive Director/Chief Executive Officer and major shareholder of UMediC Group Berhad. | Any conflict of interests that he/she has with the listed issuer | Nil | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct Interest: 300,000 shares |
Date of change | 06 Mar 2023 | Name | DR NG CHIN LIANG | Age | 31 | Gender | Male | Nationality | Malaysia | Designation | Alternate Director | Directorate | Non Independent and Non Executive | Type of change | Cessation of Office | Reason | Ceased to be Alternate Director to Dato' Ng Chai Eng | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | 1 | Doctorate | Doctor of Business Administration | Wawasan Open University | | 2 | Masters | Master of Science in Accounting and Finance | University of Exeter, United Kingdom | | 3 | Degree | Bachelor of Arts with Honours in Accounting and Finance | University of Exeter, United Kingdom | | 4 | Professional Qualification | Accountancy | Association of Chartered Certified Accountants | Fellow Member | 5 | Professional Qualification | Accountancy | Association of Chartered Certified Accountants and Malaysian Institute of Accountants | Member |
Working experience and occupation | 2015-2016: Audit Associate - Deloitte PLT2016-2018: Assistant Finance Manager - UWC Holdings Sdn Bhd (now a subsidiary company of UWC Berhad)2018-2019: Head of Corporate Affairs and Communications - UWC Berhad2019-present: Alternate director to Dato' Ng Chai Eng cum Deputy Group Chief Executive Officer of UWC Berhad | Family relationship with any director and/or major shareholder of the listed issuer | Dr. Ng Chin Liang is the son of Dato' Ng Chai Eng, the Non-Independent Non-Executive Chairman and major shareholder of UMediC Group Berhad.He is also the cousin of Mr. Lim Taw Seong, the Executive Director/Chief Executive Officer and major shareholder of UMediC Group Berhad. |
|
|
|
|
|
|
|
|
发表于 13-9-2023 06:22 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jul 2023 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jul 2023 | 31 Jul 2022 | 31 Jul 2023 | 31 Jul 2022 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 12,015 | 7,411 | 45,432 | 50,738 | 2 | Profit/(loss) before tax | 4,499 | 304 | 12,932 | 8,482 | 3 | Profit/(loss) for the period | 3,407 | 568 | 10,364 | 6,426 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,371 | 568 | 10,316 | 6,426 | 5 | Basic earnings/(loss) per share (Subunit) | 0.90 | 0.15 | 2.76 | 1.72 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1685 | 0.1409
|
|
|
|
|
|
|
|
|
发表于 6-10-2023 02:25 PM
|
显示全部楼层
Date of change | 05 Oct 2023 | Name | MR LAU CHEE KHEONG | Age | 60 | Gender | Male | Nationality | Malaysia | Designation | Non Executive Director | Directorate | Non Independent and Non Executive | Type of change | Resignation | Reason | To pursue personal matter | Details of any disagreement that he/she has with the Board of Directors | No | Whether there are any matters that need to be brought to the attention of shareholders | No | QualificationsNo | Qualifications | Major/Field of Study | Institute/University | Additional Information | 1 | Others | Secondary Education | Sekolah Menengah Jenis Kebangsaan Hua Lian in Taiping, Perak | |
Working experience and occupation | 1980-1984: Technical Supervisor - Tekskill Component Sdn Bhd1984-1986: Production Supervisor - Toriki Metal Engineering Sdn Bhd1986-1991: Assistant Factory Manager - GUH Electrical Appliances Sdn Bhd (formerly known as Leader ElectricalAppliances Manufacturing Sdn Bhd)1990-Present: Co-founder - UWC Holding Sdn Bhd (now a subsidiary company of UWC Berhad) | Family relationship with any director and/or major shareholder of the listed issuer | Nil | Any conflict of interests that he/she has with the listed issuer | Nil | Details of any interest in the securities of the listed issuer or its subsidiaries | Direct Interest in Umedic Group Berhad : 17,754,022 (4.748%)Indirect Interest in Umedic Group Berhad: 192,327,220 (51.437%) |
|
|
|
|
|
|
|
|
发表于 11-3-2024 09:14 PM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jan 2024 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jan 2024 | 31 Jan 2023 | 31 Jan 2024 | 31 Jan 2023 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 13,480 | 12,518 | 28,004 | 23,832 | 2 | Profit/(loss) before tax | 3,947 | 3,725 | 6,573 | 5,973 | 3 | Profit/(loss) for the period | 2,568 | 2,909 | 4,663 | 4,910 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 2,480 | 2,909 | 4,369 | 4,910 | 5 | Basic earnings/(loss) per share (Subunit) | 0.66 | 0.78 | 1.17 | 1.31 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1802 | 0.1685
|
|
|
|
|
|
|
|
|
发表于 23-5-2024 06:21 AM
|
显示全部楼层
Transfer of Listing
Date of Transfer | 29 Apr 2024 | Current Board | ACE Market | New Board | Main Market | Total Issued Share Capital in the following | Units | 373,910,000 | Currency | Malaysian Ringgit (MYR) | Par Value($$) (if applicable) |
| Total Issued Share Capital ($$) | 44,348,333.000 | Bursa Sector | HEALTH CARE | Bursa Sub Sector | HEALTH CARE EQUIPMENT & SERVICES | Involve Other Type of Securities Transferred? | No |
|
|
|
|
|
|
|
|
发表于 17-9-2024 02:00 AM
|
显示全部楼层
SUMMARY OF KEY FINANCIAL INFORMATION
31 Jul 2024 |
| INDIVIDUAL PERIOD | CUMULATIVE PERIOD | CURRENT YEAR QUARTER | PRECEDING YEAR
CORRESPONDING
QUARTER | CURRENT YEAR TO DATE | PRECEDING YEAR
CORRESPONDING
PERIOD | 31 Jul 2024 | 31 Jul 2023 | 31 Jul 2024 | 31 Jul 2023 | $$'000 | $$'000 | $$'000 | $$'000 |
1 | Revenue | 14,876 | 12,015 | 54,570 | 45,432 | 2 | Profit/(loss) before tax | 3,799 | 4,499 | 12,644 | 12,932 | 3 | Profit/(loss) for the period | 3,035 | 3,406 | 9,294 | 10,363 | 4 | Profit/(loss) attributable to ordinary equity holders of the parent | 3,035 | 3,370 | 8,987 | 10,315 | 5 | Basic earnings/(loss) per share (Subunit) | 0.81 | 0.90 | 2.40 | 2.76 | 6 | Proposed/Declared dividend per share (Subunit) | 0.00 | 0.00 | 0.00 | 0.00 |
|
| AS AT END OF CURRENT QUARTER | AS AT PRECEDING FINANCIAL YEAR END | 7
| Net assets per share attributable to ordinary equity holders of the parent ($$) | 0.1925 | 0.1685
|
|
|
|
|
|
|
|
| |
本周最热论坛帖子
|